Authors' response to Letter to the Editor: 'Colombian experience in the management of hepatitis C'.

We were delighted to read that centralised procurement of hepatitis C medications through the Pan American Health Organization (PAHO) has enabled Colombia to improve hepatitis C treatment access,2 demonstrating the utility of international collaboration to address a global public health issue. The data captured could also enable the economic benefits of hepatitis C elimination to be calculated,5 and used to galvanize additional funding and support for continued investment in elimination programmes in Colombia and other countries. Globally, the simplification of treatment access and facilitating treatment in community settings are central towards achieving hepatitis C elimination1 and we will be eagerly monitoring how Colombia progresses towards its 2030 elimination targets. [Extracted from the article]